Meet the First H3 Antagonist
The Carlat Psychiatry Report, Volume 17, Number 11&12, November 2019
Chris Aiken, MD
Pitolisant (Wakix) is now FDA-approved for narcolepsy and is the first histamine H3 agonist released. Though used for a neurologic condition, its novel mechanism has potential psychiatric effects that are worth monitoring.